Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin
Abstract While anecdotal evidence suggests that select 5-hydroxytryptamine 2A (5-HT2A) receptor ligands, including psilocybin, may have long-lasting therapeutic effects after limited dosing in headache